Polycystic ovary syndrome epidemiology and demographics

	Polycystic ovary syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Polycystic ovary syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Polycystic ovary syndrome epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Polycystic ovary syndrome epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Polycystic ovary syndrome epidemiology and demographics
CDC on Polycystic ovary syndrome epidemiology and demographics
Polycystic ovary syndrome epidemiology and demographics in the news
Blogs on Polycystic ovary syndrome epidemiology and demographics
Directions to Hospitals Treating Polycystic ovary syndrome
Risk calculators and risk factors for Polycystic ovary syndrome epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Polycystic ovarian syndrome (PCOS) is one of the most common endocrine disorders of reproductive-age women, with a prevalence of 4-12% in the United States. Up to 10% of women are diagnosed with PCOS.^[1]^[2]

Epidemiology

Prevalence

Approximately 5% to 10% of women of reproductive age are affected
Prevalence among first-degree relatives of patients with PCOS is 25% to 50%, suggesting a strong inheritance of the syndrome; there is evidence for possible X-linked dominant transmission

Demographics

Age

Polycystic ovary syndrome can appear anytime from menarche until menopause but generally, is seen around menarche and is diagnosed then or in early adulthood

Gender

Polycystic ovary syndrome occurs in approximately 1 in 10 women.

Race

There is no racial predilection for polycystic ovary syndrome.

References

↑ Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JC, Laven JS, Legro RS (2015). "Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome". Endocr. Rev. 36 (5): 487–525. doi:10.1210/er.2015-1018. PMC 4591526. PMID 26426951.
↑ Azziz R (2016). "Introduction: Determinants of polycystic ovary syndrome". Fertil. Steril. 106 (1): 4–5. doi:10.1016/j.fertnstert.2016.05.009. PMID 27238627.

Template:WikiDoc Sources

[pmid26426951-1] Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JC, Laven JS, Legro RS (2015). "Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome". Endocr. Rev. 36 (5): 487–525. doi:10.1210/er.2015-1018. PMC 4591526. PMID 26426951.

[pmid27238627-2] Azziz R (2016). "Introduction: Determinants of polycystic ovary syndrome". Fertil. Steril. 106 (1): 4–5. doi:10.1016/j.fertnstert.2016.05.009. PMID 27238627.

[1]

[2]